WaferGen Bio-systems Announces a Commercial Partnership with a Major Molecular Diagnostic Laboratory

WaferGen Bio-systems, Inc. (OTCQB: WGBS) announced today a commercial partnership with Molecular Pathology Laboratory Network, Inc. (MPLN) with the goal of developing Next-Generation sequencing (NGS) based clinical tests.
http://bit.ly/1AD2g2m